Arthur Przybyl is CEO & President at ANI PHARMACEUTICALS INC (ANIP). They have made 8 open-market trades across 2 companies since 2008, most recently 2020-04-07.
CIK 0001268135
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $102K since 2015, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | SELL | 2019-05-13 | 2019-05-15 | $70.07 | $2.1M | -2.0% | +1.2% | +3.4% |
| ANIP | SELL | 2019-03-18 | 2019-03-20 | $63.53 | $1.8M | +9.6% | +7.5% | +15.5% |
| ANIP | SELL | 2018-03-13 | 2018-03-14 | $61.83 | $2.5M | -5.0% | -4.2% | +8.2% |
| ANIP | SELL | 2018-03-01 | 2018-03-05 | $61.23 | $1.5M | -7.0% | -7.7% | -1.2% |
| ANIP | SELL | 2016-08-22 | 2016-08-23 | $66.97 | $2.5M | -10.6% | -0.3% | -13.9% |
| ANIP | BUY | 2015-11-12 | 2015-11-12 | $40.95 | $102K | -18.3% | -1.0% | -35.3% |
| ANIP | SELL | 2015-03-12 | 2015-03-16 | $63.00 | $4.7M | -18.3% | -1.0% | -1.0% |
| AKRX | SELL | 2008-06-20 | 2008-06-24 | $3.40 | $929K | -24.2% | +3.8% | +3.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.